Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of Uptake Period on 18F-DCFPyL-PSMA PET/CT Maximum Standardised Uptake Value.
Journal: Cancers
Published: January 27, 2025
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).
Journal: European urology oncology
Published: October 19, 2023
Expanding the role of PSMA PET in active surveillance.
Journal: BMC urology
Published: December 21, 2022
Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study).
Journal: European urology open science
Published: November 23, 2022
PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
Journal: BMJ open
Published: September 19, 2022
Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Journal: European radiology
Published: May 11, 2015
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 04, 2015
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Journal: The Prostate
Published: April 21, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026